- Home
- NVX vs SCPH Comparison
NVX vs SCPH Comparison
Compare NVX & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- SCPH
- Stock Information
- Founded
- NVX 2012
- SCPH 2013
- Country
- NVX Australia
- SCPH United States
- Employees
- NVX N/A
- SCPH N/A
- Industry
- NVX Industrial Machinery/Components
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NVX Miscellaneous
- SCPH Health Care
- Exchange
- NVX Nasdaq
- SCPH Nasdaq
- Market Cap
- NVX 176.8M
- SCPH 173.6M
- IPO Year
- NVX N/A
- SCPH 2017
- Fundamental
- Price
- NVX $1.10
- SCPH $4.51
- Analyst Decision
- NVX
- SCPH Strong Buy
- Analyst Count
- NVX 0
- SCPH 3
- Target Price
- NVX N/A
- SCPH $14.00
- AVG Volume (30 Days)
- NVX 59.8K
- SCPH 276.4K
- Earning Date
- NVX 01-01-0001
- SCPH 08-13-2025
- Dividend Yield
- NVX N/A
- SCPH N/A
- EPS Growth
- NVX N/A
- SCPH N/A
- EPS
- NVX N/A
- SCPH N/A
- Revenue
- NVX $5,854,424.00
- SCPH $41,982,000.00
- Revenue This Year
- NVX $66.66
- SCPH $108.95
- Revenue Next Year
- NVX $2,366.64
- SCPH $73.83
- P/E Ratio
- NVX N/A
- SCPH N/A
- Revenue Growth
- NVX N/A
- SCPH 138.10
- 52 Week Low
- NVX $0.81
- SCPH $1.94
- 52 Week High
- NVX $2.73
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- NVX 46.92
- SCPH 60.01
- Support Level
- NVX $1.06
- SCPH $3.83
- Resistance Level
- NVX $1.21
- SCPH $4.18
- Average True Range (ATR)
- NVX 0.06
- SCPH 0.17
- MACD
- NVX 0.01
- SCPH -0.02
- Stochastic Oscillator
- NVX 42.14
- SCPH 76.60
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.